{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:06:12Z","timestamp":1781665572786,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.clindermatol.2020.10.009","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T16:55:25Z","timestamp":1602867325000},"page":"283-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Immunoglobulin-G4\u2013related skin disease"],"prefix":"10.1016","volume":"39","author":[{"given":"Roula","family":"Katerji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Smoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2020.10.009_bb0005","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/1756-185X.12586","article-title":"IgG4-related disease","volume":"19","author":"Kubo","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/MPG.0b013e31820e82a1","article-title":"A 3-year-old with immunoglobulin G4-associated cholangitis","volume":"53","author":"Ibrahim","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.anl.2011.01.023","article-title":"A novel concept of Mikulicz\u2019s disease as IgG4-related disease","volume":"39","author":"Himi","year":"2012","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0025","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2008.089169","article-title":"Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders","volume":"68","author":"Masaki","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0030","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0035","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease","volume":"138","author":"Mattoo","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/ar4122","article-title":"IgG4-related disease: why high IgG4 and fibrosis?","volume":"15","author":"Koike","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/08916934.2017.1280029","article-title":"Clonally expanded cytotoxic CD4(+) T cells and the pathogenesis of IgG4-related disease","volume":"50","author":"Mattoo","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0050","article-title":"Circulating PD-1(+)CXCR5(-)CD4(+) T cells underlying the immunological mechanisms of IgG4-related disease","volume":"2","author":"Kamekura","year":"2018","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0055","article-title":"Different clinical patterns of IgG4-RD patients with and without eosinophilia","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0060","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/gutjnl-2012-304224","article-title":"Recent advances in autoimmune pancreatitis: type 1 and type 2","volume":"62","author":"Kamisawa","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/PAS.0b013e3181c811ad","article-title":"Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease","volume":"34","author":"Geyer","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0070","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/radiol.11102250","article-title":"Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients","volume":"261","author":"Inoue","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0075","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/resp.12016","article-title":"Immunoglobulin G4-related lung disease: clinicoradiological and pathological features","volume":"18","author":"Matsui","year":"2013","journal-title":"Respirology"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0080","first-page":"11747","article-title":"IgG4-related prostatitis progressed from localized IgG4-related lymphadenopathy","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/j.semdp.2017.11.006","article-title":"Lymphadenopathy associated with IgG4-related disease: diagnosis & differential diagnosis","volume":"35","author":"Wick","year":"2018","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1827.2010.02524.x","article-title":"IgG4-related disease: historical overview and pathology of hematological disorders","volume":"60","author":"Sato","year":"2010","journal-title":"Pathol Int"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/all.12320","article-title":"Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease","volume":"69","author":"Della Torre","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0100","article-title":"IgG4-related disease presenting as a pancreatic mass and bilateral lacrimal gland swelling","volume":"9","author":"Ibrahim","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0105","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.mayocp.2015.03.020","article-title":"Diagnostic approach to the complexity of IgG4-related disease","volume":"90","author":"Stone","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0110","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0115","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0120","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00393-016-0142-y","article-title":"Treatment of IgG4-related disease: current and future approaches","volume":"75","author":"Perugino","year":"2016","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0125","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jamadermatol.2013.2625","article-title":"IgG4-related skin disease successfully treated by thalidomide: a report of 2 cases with emphasis on pathological aspects","volume":"149","author":"Ingen-Housz-Oro","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0130","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/s10165-011-0520-x","article-title":"Risk of malignancies in IgG4-related disease","volume":"22","author":"Yamamoto","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0135","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/ijd.13369","article-title":"IgG4-related skin disease may have distinct systemic manifestations: a systematic review","volume":"55","author":"Bennett","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaad.2016.01.046","article-title":"Cutaneous manifestations of IgG4-related disease (RD): a systematic review","volume":"75","author":"Charrow","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0145","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3109\/s10165-012-0786-7","article-title":"Investigations of IgG4-related disease involving the skin","volume":"23","author":"Yamada","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-224814","article-title":"IgG4-related disease coexisting with autoimmune haemolytic anaemia","volume":"2018","author":"Wang","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0155","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijscr.2018.07.030","article-title":"IgG4-related disease mimicking pancreatic cancer: case report and review of the literature","volume":"50","author":"Sulieman","year":"2018","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0160","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/modpathol.2012.196","article-title":"Clinicopathologic analysis of IgG4-related skin disease","volume":"26","author":"Sato","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0165","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/1346-8138.13723","article-title":"Immunoglobulin G4-related disease and its skin manifestations","volume":"44","author":"Takayama","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181888","article-title":"Elevated IgG4 serum levels in patients with cystic fibrosis","volume":"12","author":"Clerc","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0175","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-2133.2012.11144.x","article-title":"Enrichment of total serum IgG4 in patients with pemphigus","volume":"167","author":"Funakoshi","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0180","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1309\/AJCPTMWTCN04GSJH","article-title":"Increased immunoglobulin (Ig) G4\u2013positive plasma cell density and IgG4\/IgG ratio are not specific for IgG4-related disease in the skin","volume":"141","author":"Lehman","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0185","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bjd.13296","article-title":"IgG4-related skin disease","volume":"171","author":"Tokura","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0190","first-page":"537","article-title":"Two cases of generalized pustular psoriasis complicated by IgG4-related disease","volume":"179","author":"Miyazawa","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0195","first-page":"226","article-title":"Immunoglobulin G4-related disease with recurrent uveitis and kidney tumor mimicking childhood polyarteritis nodosa: a rare case report","volume":"43","author":"Nastri","year":"2018","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0200","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/bjd.14628","article-title":"Nodules behind the ears: IgG4-related skin disease","volume":"175","author":"Kondo","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0205","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0210","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0360-3016(97)89487-4","article-title":"Radiation treatment in patients with recurrent Kimura\u2019s disease","volume":"38","author":"Kim","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0215","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-214211","article-title":"Eosinophilia and multiple lymphadenopathy: Kimura disease, a rare, but benign condition","volume":"2016","author":"Garcia Carretero","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0220","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaad.2015.10.011","article-title":"Epidemiology and treatment of angiolymphoid hyperplasia with eosinophilia (ALHE): a systematic review","volume":"74","author":"Adler","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0225","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.5858\/2005-129-1168-AHWEAW","article-title":"Angiolymphoid hyperplasia with eosinophilia associated with pregnancy: a case report and review of the literature","volume":"129","author":"Zarrin-Khameh","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0230","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00002030-199507000-00023","article-title":"Angiolymphoid hyperplasia with eosinophils in HIV infection","volume":"9","author":"D\u2019Offizi","year":"1995","journal-title":"AIDS"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0235","first-page":"334","article-title":"Angiolymphoid hyperplasia with eosinophilia and nephrotic syndrome","volume":"56","author":"Altman","year":"1995","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000433545","article-title":"Angiolymphoid hyperplasia with eosinophilia of the orbit and adnexa","volume":"2","author":"Mukherjee","year":"2015","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0245","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1177\/0003489416646796","article-title":"Angiolymphoid hyperplasia with eosinophilia within a vascular malformation: case report and review of the literature","volume":"125","author":"Fontana","year":"2016","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0250","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1017\/S0022215114002552","article-title":"Eosinophilic angiocentric fibrosis of the nose and sinuses","volume":"128","author":"Rimmer","year":"2014","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0255","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12105-015-0620-6","article-title":"IgG4 related disease of the head and neck","volume":"9","author":"Deshpande","year":"2015","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0260","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1600-0560.2011.01760.x","article-title":"Erythema elevatum diutinum - a chronic leukocytoclastic vasculitis microscopically indistinguishable from granuloma faciale?","volume":"38","author":"Ziemer","year":"2011","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0265","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jaad.2005.08.021","article-title":"Granuloma faciale: a clinicopathologic study of 66 patients","volume":"53","author":"Ortonne","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0270","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/PAS.0b013e318271efd0","article-title":"Granuloma faciale: a cutaneous lesion sharing features with IgG4-associated sclerosing diseases","volume":"37","author":"Cesinaro","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0275","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/ajcp\/aqw004","article-title":"Granuloma faciale and erythema elevatum diutinum in relation to immunoglobulin G4-related disease: an appraisal of 32 cases","volume":"145","author":"Kavand","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0280","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000246848","article-title":"Primary cutaneous plasmacytosis: report of three cases and review of the literature","volume":"189","author":"Uhara","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0285","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/DAD.0000000000000907","article-title":"Cutaneous plasmacytosis: a clinicopathologic study of a series of cases and their treatment outcomes","volume":"40","author":"Han","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2020.10.009_bb0290","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.humpath.2009.01.013","article-title":"High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis\u2014is this a cutaneous manifestation of IgG4-related disease?","volume":"40","author":"Miyagawa-Hayashino","year":"2009","journal-title":"Hum Pathol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:18:37Z","timestamp":1760033917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X20301887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0738081X20301887"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.10.009","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoglobulin-G4\u2013related skin disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}